ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 647117 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 647117; 2) Community: the network communities that were significantly associated with the response to NSC 647117; 3) Molecule: the relationships between components within communities and NSC 647117; 4) MDR: the compounds that were significantly associated with the NSC 647117.

NSC Compound Enrichment Correlation
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0422011701988039 0.11523585
NSC 679586 Peridinin 0.0422011701988039 0.10326781
NSC 679800 Null 0.0422011701988039 0.21128997
NSC 681636 Camptothecin Derivative 0.0422011701988039 0.24256346
NSC 681645 Camptothecin Derivative 0.0422011701988039 0.2559317
NSC 683864 Temsirolimus 0.0422011701988039 0.060955018
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0422011701988039 0.18528679
NSC 691127 Null 0.0422011701988039 0.41929726
NSC 691845 Null 0.0422011701988039 0.096892469
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0422011701988039 -0.16428659
Total:110  Current:89    [First] [Prev] [Next] [Last]